Trending...
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
~ Q'Apel Medical (Q'Apel), a leading medical device company, has recently announced the receipt of CE mark certification for its innovative Armadillo SelectFlex™ Neurovascular Access System. This groundbreaking 7F system, equipped with patented SelectFlex™ Technology, is specifically designed to simplify neurovascular interventions.
According to Pascal Jabbour, MD, FAANS, FACS, FAHA, The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology at Thomas Jefferson University Hospital in Philadelphia, PA, navigating the complex anatomy of the neurovasculature can be extremely challenging. While flexible access catheters are necessary for maneuvering through tight twists and turns, they often lack the necessary support and stability for device delivery once in position. However, with Armadillo's one-and-done solution, physicians can easily transform the catheter from highly trackable to highly supportive as needed throughout the procedure with just a simple injection or withdrawal of 0.2cc of saline.
More on The PennZone
The Armadillo Neurovascular Access System with SelectFlex™ Technology offers physicians the versatility they need to confidently tackle a wide range of neurovascular interventions. Its low-profile 7F catheter allows for a biaxial approach regardless of access site, accelerating delicate procedures and eliminating the complexity and cost associated with conventional tri-axial configurations.
Jodie Fam, CEO of Q'Apel Medical, believes that their new system addresses the limitations of current neurovascular access catheters. She states that it provides a unique option for hospitals to standardize device usage while reducing inventory constraints and cost per procedure. Fam also expresses her gratitude towards their team for achieving this critical milestone and looks forward to expanding their international portfolio by delivering this meaningful solution to the European market and beyond in the coming months.
With its revolutionary technology and potential cost-saving benefits for hospitals, Q'Apel's Armadillo SelectFlex™ Neurovascular Access System is set to revolutionize neurovascular interventions and improve patient outcomes. The company's success in the U.S. market has paved the way for its expansion into the international market, bringing this innovative solution to more physicians and patients in need.
According to Pascal Jabbour, MD, FAANS, FACS, FAHA, The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology at Thomas Jefferson University Hospital in Philadelphia, PA, navigating the complex anatomy of the neurovasculature can be extremely challenging. While flexible access catheters are necessary for maneuvering through tight twists and turns, they often lack the necessary support and stability for device delivery once in position. However, with Armadillo's one-and-done solution, physicians can easily transform the catheter from highly trackable to highly supportive as needed throughout the procedure with just a simple injection or withdrawal of 0.2cc of saline.
More on The PennZone
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
- CLASS ACTION REMINDER: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025
- Colbert Packaging Announces WBENC Recognition
- SHI Cryogenics Group Launches Highest-Capacity Single-Stage Cryocoolers to Date
The Armadillo Neurovascular Access System with SelectFlex™ Technology offers physicians the versatility they need to confidently tackle a wide range of neurovascular interventions. Its low-profile 7F catheter allows for a biaxial approach regardless of access site, accelerating delicate procedures and eliminating the complexity and cost associated with conventional tri-axial configurations.
Jodie Fam, CEO of Q'Apel Medical, believes that their new system addresses the limitations of current neurovascular access catheters. She states that it provides a unique option for hospitals to standardize device usage while reducing inventory constraints and cost per procedure. Fam also expresses her gratitude towards their team for achieving this critical milestone and looks forward to expanding their international portfolio by delivering this meaningful solution to the European market and beyond in the coming months.
With its revolutionary technology and potential cost-saving benefits for hospitals, Q'Apel's Armadillo SelectFlex™ Neurovascular Access System is set to revolutionize neurovascular interventions and improve patient outcomes. The company's success in the U.S. market has paved the way for its expansion into the international market, bringing this innovative solution to more physicians and patients in need.
Filed Under: Business
0 Comments
Latest on The PennZone
- Centennial Flyers to Become Colorado's First Launch Customer for All-Electric B23 Energic Aircraft
- Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- LDR Partners LP Announces Acquisition of Active Radiator, and Combination with Cincinnati Radiator and Ohio Heat Transfer, Forming the Largest U.S. Heavy Manufacturing Platform for Aluminum Industrial Heat Exchangers
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
- Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
- Sidney and Caroline Kimmel Invest in the Future of Care and Discovery at Jefferson
- Abide Capital Acquires Columbus, OH Apartment Community for $16.5 Million
- Miami Real Estate Agent Drastically Increases Interest In Homes
- Adostics & Genmega Announce the Introduction of A-POD
- QVC Kicks Off 'Christmas in July' with Star-Studded Merrymakers Lineup: Elton John, Martha Stewart, Kathy Hilton, Kim Gravel and Babs Costello as Chief Cheer Officer
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
- The Waite Launches: A Curated Motherhood Marketplace For Every Stage
- Affordable, High-Quality Care: Cheap Braces for Adults Available from Exeter Smiles in Reading
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Sci-Fi Novel from Pittsburgh Author Explores Love, Power, & Humanity in an Age of Artificial People
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media